What is the recommended doxycycline dosage for treating a skin infection in an adult with normal liver and kidney function?

Doxycycline Dosing for Skin Infections

For most adult skin and soft tissue infections, doxycycline 100 mg twice daily is the recommended dose, with a loading dose of 200 mg on day 1 optional for more severe infections.

Standard Dosing Regimen

The FDA-approved dosing for doxycycline in adults with normal renal and hepatic function is 1:

• Loading dose: 200 mg on day 1 (can be given as 100 mg every 12 hours or 200 mg once)
• Maintenance: 100 mg every 12 hours thereafter
• For severe infections, 200 mg daily can be continued throughout treatment

Evidence-Based Context

Skin and Soft Tissue Infections

Recent high-quality evidence demonstrates doxycycline's effectiveness for nonpurulent (presumed streptococcal) skin infections. A 2024 propensity-matched study showed doxycycline had equivalent clinical outcomes to cephalexin, with only 6% clinical failure rates in both groups 2. This supports doxycycline as a reasonable first-line alternative for streptococcal skin infections in regions with low tetracycline resistance.

Specific Infections from Guidelines

The 2014 IDSA guidelines provide dosing for specific skin-related infections 3:

• Tularemia (mild cases): Doxycycline 100 mg twice daily orally
• Bubonic plague: Doxycycline 100 mg twice daily orally
• Other susceptible organisms: Based on in vitro susceptibility

Pharmacokinetic Considerations

Doxycycline has favorable properties for skin infections 1, 4:

• Virtually complete oral absorption (not significantly affected by food)
• Excellent tissue penetration into skin and soft tissues
• Half-life of 18-22 hours allows for twice-daily dosing
• No dose adjustment needed in renal insufficiency, unlike other tetracyclines

Duration of Therapy

While the evidence doesn't specify exact duration for all skin infections:

• Most uncomplicated skin infections: 7-14 days is standard
• The 2024 study used ≤14 days successfully 2
• Severe infections may require longer courses based on clinical response

Important Caveats

Resistance Concerns

• Up to 44% of Streptococcus pyogenes strains may be tetracycline-resistant 1
• Culture and susceptibility testing are recommended when feasible
• Consider alternative agents if local resistance rates are high
• Recent data suggests emerging multidrug resistance patterns in some populations 5

When NOT to Use Doxycycline

• Staphylococcal infections: The 2011 IDSA MRSA guidelines do not recommend doxycycline as first-line therapy 6
• Purulent/abscess-forming infections: These typically require incision and drainage plus anti-staphylococcal coverage
• Known tetracycline resistance: Choose alternative based on susceptibilities

Monitoring

• No therapeutic drug monitoring required for standard skin infections 1
• Assess clinical response at 48-72 hours
• If no improvement, consider alternative diagnosis or resistant organism

Practical Algorithm

1. Identify infection type: Nonpurulent (cellulitis, erysipelas) vs purulent (abscess)
2. For nonpurulent infections: Doxycycline 100 mg twice daily is appropriate
3. Consider loading dose (200 mg day 1) for more extensive infections
4. Reassess at 48-72 hours for clinical improvement
5. Complete 7-14 days based on severity and response

The key advantage of doxycycline is its excellent oral bioavailability, tissue penetration, and lack of need for renal dose adjustment, making it a practical outpatient option for appropriate skin infections 1, 4.